Sarcoma

LECTURES & BREAKOUTS Monday, June 17, 2002
	Time	Title	Speaker

	8:00	Welcome and introduction to the NCI State of the Science Meetings	Scott Saxman, MD

		Overview and Charge for the Sarcoma SOTS Meeting	Ernest C. Borden, MD

	8:15	Epidemiology and Prognostic Assessment of Soft Tissue Sarcomas	Murray F. Brennan, MD

	8:35	Pathology of Soft Tissue Sarcomas	Christopher Fletcher, MD

	8:55	Molecular Pathogenesis of Soft Tissue Sarcomas	Marc Ladanyi, MD

	9:15	Classification Enhancements of Arrays	Paul Meltzer, MD, PhD

	9:35	Imaging Issues in Soft Tissue Sarcomas	Murali Sundaram, MD

	9:55	Strategies for Therapeutic Targeting	David R Parkinson, MD

	10:40	Panel Discussion

	11:20	Primary Management of Soft Tissue Sarcomas: Current Approaches and Challeges	Samuel Singer, MD

	11:40	Retroperitoneal Sarcomas	Burton L. Eisenberg, MD

	1:15	Balancing Morbidity and Outcome	Brian O'Sullivan, MD

	1:35	Targeted Therapeutics: The GIST Prototype	Allan Van Oosterom, MD, PhD

	1:55	Other Potential Targets in Soft Tissue Sarcomas	George D. Demetri, MD

	2:15	Panel Discussion

	6:00	Keynote Speaker	Andrew von Eschenbach, MD

Tuesday June 18, 2002
	Time	Title	Speaker

	8:15	Announcements	Scott Saxman, MD
		Introduction	Ernest C. Borden, MD

	8:45	Breakout Group A Summary and Recomendations with Group Discussion: Pathology, Molecular Profiling, Prognosis	Sharon W. Weiss, MD
			Discussion
			Jonathan A. Fletcher, MD
			Discussion

	10:00	Breakout Group B Summary and Recomendations with Group Discussion: Therapuetic Intervetion/Targeted Therapies for Systemic Disease	Laurence H. Baker, MD
	10:00		Jaap Verweij, MD, PhD
			Discussion

	11:00	Breakout Group C Summary and Recomendations with Group Discussion: Improving Therapy and Reducing Morbidity of Primary Therapy for Localized Disease	Robert S. Bell, MD
			Discussion
			Robert S. Bell, MD
			Discussion
			Peter W.T. Pisters, MD
			Discussion

	12:00	Summary and Closing Remarks	Ernest C. Borden, MD Murray F. Brennan, MD

	12:15	Adjourn